Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (1021-1030 of 1,920) with videos related to

Pageof 192
Sort By:
RMD Open|February 4, 2022
Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patientsSimeon Schietzel, Manuel Anderegg, Andreas Limacher, et al.
RMD Open|February 16, 2022
Allergic conditions and risk of rheumatoid arthritis: a Swedish case-control studyVanessa L Kronzer, Helga Westerlind, Lars Alfredsson, et al.
RMD Open|January 25, 2022
Characterising axial psoriatic arthritis: correlation between whole spine MRI abnormalities and clinical, laboratory and radiographic findingsPamela Diaz, Joy Feld, Iris Eshed, et al.
RMD Open|July 22, 2022
Recurrence of axial spondyloarthritis among first-degree relatives in a prospective 35-year-follow-up family studySjef M van der Linden, Muhammad Asim Khan, Zhixiu Li, et al.
RMD Open|July 12, 2022
The value of MRI for detecting subclinical joint inflammation in clinically suspect arthralgiaAnna M P Boeren, Edwin H G Oei, Annette H M van der Helm-van Mil
RMD Open|July 15, 2022
Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance dataImke Redeker, Anja Strangfeld, Johanna Callhoff, et al.
RMD Open|July 19, 2022
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trialXenofon Baraliakos, Effie Pournara, Laure Gossec, et al.
RMD Open|February 18, 2022
SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathiesManuel Graf, Sae Lim von Stuckrad, Akinori Uruha, et al.
RMD Open|February 21, 2022
Development of a patient decision aid for the initiation of urate-lowering therapy in gout patientsRitch Te Kampe, Annelies Boonen, Tim Jansen, et al.
RMD Open|May 18, 2018
Correction: Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example
Pageof 192

Showing results (1021-1030 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|February 4, 2022
Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patientsSimeon Schietzel, Manuel Anderegg, Andreas Limacher, et al.
RMD Open|February 16, 2022
Allergic conditions and risk of rheumatoid arthritis: a Swedish case-control studyVanessa L Kronzer, Helga Westerlind, Lars Alfredsson, et al.
RMD Open|January 25, 2022
Characterising axial psoriatic arthritis: correlation between whole spine MRI abnormalities and clinical, laboratory and radiographic findingsPamela Diaz, Joy Feld, Iris Eshed, et al.
RMD Open|July 22, 2022
Recurrence of axial spondyloarthritis among first-degree relatives in a prospective 35-year-follow-up family studySjef M van der Linden, Muhammad Asim Khan, Zhixiu Li, et al.
RMD Open|July 12, 2022
The value of MRI for detecting subclinical joint inflammation in clinically suspect arthralgiaAnna M P Boeren, Edwin H G Oei, Annette H M van der Helm-van Mil
RMD Open|July 15, 2022
Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance dataImke Redeker, Anja Strangfeld, Johanna Callhoff, et al.
RMD Open|July 19, 2022
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trialXenofon Baraliakos, Effie Pournara, Laure Gossec, et al.
RMD Open|February 18, 2022
SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathiesManuel Graf, Sae Lim von Stuckrad, Akinori Uruha, et al.
RMD Open|February 21, 2022
Development of a patient decision aid for the initiation of urate-lowering therapy in gout patientsRitch Te Kampe, Annelies Boonen, Tim Jansen, et al.
RMD Open|May 18, 2018
Correction: Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example
Pageof 192